NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

元基因組測序的全球市場:2020-2027

Global Metagenomic Sequencing Market - 2020-2027

出版商 DataM Intelligence 商品編碼 961174
出版日期 按訂單生產 內容資訊 英文
商品交期: 請詢問到貨日
價格
元基因組測序的全球市場:2020-2027 Global Metagenomic Sequencing Market - 2020-2027
出版日期: 按訂單生產內容資訊: 英文
簡介

元基因組學是研究來自環境界的微生物DNA的基因組分析的領域。元基因組測序技術使科學家能夠分析特定樣品中的基因。這種方法使研究人員能夠評估細菌多樣性並確定各種環境中微生物的存在。元基因組測序包括DNA提取,文庫調整,測序,組裝,註釋和統計分析。

該報告研究和分析了全球基因組測序市場,並提供了有關行業分析,細分市場分析,競爭條件,主要公司等的系統信息。

目錄

第1章全球基因組測序市場:研究方法和範圍

第2章全球元基因組測序市場:市場定義和概述

第3章全球元基因組測序市場:執行摘要

第4章全球元基因組測序市場:市場動態

  • 影響市場的因素
    • 促進因素
    • 抑製器
    • 機會
    • 影響分析

第5章全球元基因組測序市場:行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 臨床試驗
  • 價格分析
  • 監管分析
  • 贖回分析
  • 未滿足的需求

第6章全球元基因組測序市場:COVID-19分析

  • 針對市場的COVID-19分析
  • COVID-19的價格趨勢
  • 供需範圍
  • 大流行期間與市場有關的政府舉措
  • 製造商的戰略計劃
  • 結論

第7章全球元基因組測序市場:按產品/服務

  • 簡介
  • 市場規模分析/同比增長分析:按產品/服務細分
  • 市場吸引力指數:按產品/服務分類
    • 儀器
    • 試劑/消耗品
    • 分析/數據解釋解決方案
    • 服務
    • 其他

第8章全球元基因組測序市場:按工作流程

  • 簡介
  • 市場規模分析/同比增長分析:按工作流程
  • 市場吸引力指數:按工作流細分
    • 數據處理/分析
    • 樣品處理/庫調整
    • 排序

第9章全球元基因組測序市場:按技術

  • 簡介
  • 市場規模分析/同比增長分析:按技術領域劃分
  • 市場吸引力指數:按技術領域劃分
    • Shot彈槍基因組測序
    • 16S rRNA測序
    • 從頭開始進行全基因組測序
    • 元轉錄本組合

第10章全球元基因組測序市場:按用途

  • 簡介
  • 市場規模分析/同比增長分析:按應用細分
  • 市場吸引力指數:按用途細分
    • 藥物發現
    • 臨床診斷
    • 動物藥
    • 生態/環境
    • 行業
    • 土壤微生物組
    • 其他

第11章全球元基因組測序市場:按地區

  • 簡介
  • 市場規模分析/同比增長分析:按地區
  • 市場吸引力指數:按地區
  • 北美
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第12章全球元基因組測序市場:競爭形勢

  • 競爭情景
  • 市場定位/份額分析
  • 併購分析

第13章全球宏基因組測序市場:公司概況

  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • BGI Group
  • DNAstar, Inc.
  • Eurofins Scientific
  • Illumina, Inc.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies Ltd.
  • NuGEN Technologies, Inc. (A Wholly Owned Subsidiary of Tecan Trading AG)
  • F. Hoffmann-La Roche Ltd.
  • Perkinelmer, Inc.
  • Integragen SA
  • Microsynth AG
  • Novogene Co., Ltd.
  • Zymo Research Corporation、スジ

第14章全球元基因組測序市場:重要討論

第15章全球元基因組測序市場:DataM

目錄

Market Overview

The global metagenomic sequencing market size was worth US$ XX billion in 2018 and is estimated to reach US$ XX billion by 2027, growing at a CAGR of XX % during the forecast period (2020-2027).

Metagenomics is a research field where genomic analysis of microbial DNA from environmental communities is studied. Metagenomic sequencing techniques enable scientists to analyze genes in the given sample. The method allows researchers to assess bacterial diversity and identify the presence of microbes in various environments. Steps involved in metagenomics sequencing include DNA extraction, library preparation, sequencing, assembly, annotation and statistical analysis.

Market Dynamics

Advanced technological platforms and improved genomic tools

One of the major factor driving the growth of metagenomics sequencing market is the continuous development of faster sequencing techniques and advancements in different methods to cope with the huge data generated, which are expanding researchers' capacity to analyze microbial communities from an unlimited variety of environments.

The growing adoption of advanced bioinformatics tools, high throughput screening (HTS) methods, recovery of novel drugs, and development of cost-effective technologies such as next-generation sequencing (NGS) are driving the market growth. The development of Next Generation DNA Sequencing (NGS) technology has driven molecular biology research, leading to several discoveries and new insights. Next-generation DNA sequencing technology goes beyond long-established DNA sequencing with its applications that reach across the principles of molecular biology.

In May 28, 2019, precision medical biotechnology company, Macrogen, Inc. received South Korean accreditation of Good Clinical Lab Practices from the country's Ministry of Food and Drug Safety (MFDS) and designated as clinical trial specimen analysis institution. It would benefit Macrogen with improvised clinical diagnostic metagenomics.

Hence, increasing technological advancements regarding DNA sequencing is expected to drive market growth over the forecast period.

Increasing initiatives and funds by government and private organizations to large scale projects of sequencing

The growing awareness towards the genetic disorders and increasing government initiatives and funds to large scale projects of sequencing are among the major factor driving the growth of the global metagenomic sequencing market. For instance, in 2019, QIAGEN got into a partnership with multiple organizations in the UK to support and establish its global genomics campus in Manchester (UK). The new Genomic Health Innovation Campus will aim at innovation in life sciences, translational sciences, and the molecular diagnostics field.

Also, in November 2019, The "Million Microbiome of Humans Project" (MMHP) was officially launched at the 14th International Conference on Genomics (ICG-14). Scientists from China, France, Sweden, Denmark, Latvia and other countries will cooperate in microbial metagenomic research, aiming to sequence and analyze one million microbial samples from intestines, skin, mouth, reproductive tract and other organs in the next 3-5 years to draw a microbiome map of the human body and build the world's largest database of the human microbiome.

Factors hampering the growth of metagenomics sequencing market

However, the market growth is hampered by several factors such as growing concerns towards the standardization and accuracy of diagnostic testing, its requirement for parallel advancement in various isolation and identification techniques, more efficient & robust bioinformatics tools, and lack of skilled professionals.

COVID-19 Impact Analysis

The metagenomic sequencing market is positively impacted by COVID-19 as, throughout the COVID-19 pandemic, testing is a critical component of the response and rapidly increasing, which enables rapid identification and isolation of infected individuals. Majority of this testing is PCR-based, detecting the presence of the SARS-CoV-2 virus only.

Next-generation sequencing (NGS) of the COVID-19 virus is providing powerful metagenomic data, that is combined with clinical data to search for effective treatments. Continous genomic and epigenomic analysis of SARS-CoV-2 is critical, used to determine the number of virus strains, how the virus is spread into new regions, number of introductions of the virus if there is community spread of the virus if outbreaks are linked, and how the virus is evolving.

Oxford Nanopore Technologies is doing the Metagenomic analysis of SARS-CoV-2 respiratory samples via Sequence-Independent Single Primer Amplification (SISPA) and nanopore sequencing.

Segment Analysis

The global metagenomic sequencing market is segmented on the basis of product and service, technology , workflow, and application.

Sample processing & library preparation estimated to dominate the market

On the basis of workflow, the metagenomic sequencing market is classified as sample processing and library preparation, sequencing, data processing and analysis. Among these, sample processing and library preparation segment accounted for the largest segment in 2019, owing to the increasing number of metagenome sequencing research projects, wide availability of technically advanced and robust sample processing.

Reagents & consumables dominating the metagenomic sequencing market with the largest share in 2019

Based on products & services, the metagenomic sequencing market is segmented into instruments, reagents & consumables, analysis & data interpretation solutions, and services. Among these, the reagents & consumables accounted for the largest share of the market in 2019, due to growing demand for sequencing reagents by end-users and the development of high-quality reagents and kits.

By technology, shotgun metagenomic sequencing technology is expected to grow at fastest CAGR during the forecast period.

By technology, the metagenomic sequencing market is segmented into 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing & de-novo assembly, and metatranscriptomics. Out of all these segments, the shotgun metagenomic sequencing technology is growing at the fastest growth rate over the forecast period, due to growing adoption of shotgun metagenomic sequencing among researchers and healthcare professionals, several advantages offered by shotgun sequencing compared with other techniques, and the increasing number of metagenomic sequencing-based research activities. Shotgun sequencing can detect low abundance members of microbial communities. Shotgun metagenome sequencing can target all genes from all organisms found in an environmental sample, in contrast to the whole sequencing and targeting all genes from only one organism.

The drug discovery segment of applications accounted for the largest share in 2019

On the basis of applications, the metagenomic sequencing market is classified into clinical diagnostics, drug discovery, industrial applications , veterinary application, soil microbiome applications, ecological and environmental applications, and others. Among these, the drug discovery segment accounted for the largest share in 2019, owing to the rising number of research activities for novel drug discovery, increasing collaborations among major players, pharmaceutical companies, and academic institutions for drug development, and growing use of metagenomic NGS in clinical trials.

Geographical Analysis

North America region holds the largest market share in global Metagenomic Sequencing market

North America region is dominating the global metagenomic sequencing market accounted for the largest market share in 2019, owing to technological advancements in the next-generation sequencing procedures along with its increasing applications, favourable initiatives by government and private bodies for the development and adoption of NGS-based metagenomics technologies, the wide adoption of metagenomic diagnostics in the region, and rising awareness of metagenomics sequencing services. The market players are collaborating to introduce new procedures with innovative technology. For instance, In 2019, Illumina and Thermo Fisher Scientific (U.S.) entered into a commercial agreement for the sales of Thermo Fisher's Ion AmpliSeq technology to researchers who use Illumina's NGS platforms.

Europe market is growing significantly with increasing collaboration and projects related to metagenomic sequencing

The European market accounted for the second-largest share in the global metagenomic sequencing market due to the growing investment by the government and hospital facilities, increasing collaborations and partnerships by major players, and growing adoption of NGS procedure by research laboratories.

In July 2020, Australian microbial genetics firm Microba has signed an agreement with German medical diagnostic services provider Synlab to launch a gut microbiome test, MyBiome, in Europe and Latin America. The test measures bacterial species in the gut microbiome and calculates their metabolic potential in relation to healthy reference ranges. The product launch will bring its whole-genome metagenomic sequencing and bioinformatics software to new markets, and Synlab will make a new gastrointestinal testing service available to its network of doctors and clinics.

In 2016, QIAGEN N.V. acquired Exiqon A/S (Denmark) which helped QIAGEN leverage Exiqon's advanced Locked Nucleic Acid (LNA) technology to improve the sensitivity of PCR and NGS assays.

Asia-Pacific region is growing at the fastest CAGR during the forecast period

The Asia Pacific market is expected to grow at the fastest CAGR during the forecast period, due to the rising prevalence of genetic disorders and an increasing number of research projects. Major players are focusing on this region and investing money to expand their network that is helping them to capture a major piece of the market. In 2019, Illumina and KingMed Diagnostics (China) partnered to co-develop oncology & hereditary disease testing applications based on Illumina's NGS technology.

Competitive Landscape

The metagenomic sequencing market is highly competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., BGI Group, DNAstar, Inc., Eurofins Scientific, Macrogen, Inc., Oxford Nanopore Technologies Ltd., Brooks Automation, Inc. (GENEWIZ), Perkinelmer, Inc., among others.

Illumina, Inc.

Overview: llumina, Inc. was incorporated in April 1998 and headquarter located in San Diego, California. The company develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets.

Product Portfolio: The company's product portfolio includes a wide range of highly interconnected products, including sequencing, genotyping, gene expression, and molecular diagnostic products. Illumina also offers metagenomic sequencing services, which further strengthens its market position.

Key Development: In 2019, Illumina and Lundbeck Foundation GeoGenetics Centre (Denmark) collaborated to generate one of the largest ancient genome datasets. This partnership will also help explore the relationship between the evolutionary history of select mental & neurological disorders and infectious pathogens.

The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the metagenomic sequencing market globally. For instance,

  • In 2019, Illumina acquired Pacific Biosciences, one of the leading provider of sequencing systems. This helped Illumina strengthen its sequencing product portfolio.
  • In 2019, Illumina acquired Edico Genome, a software provider for NGS.
  • In 2019, Microba had partnered with Macrogen to develop microbiome research services for international markets.
  • In 2019, Eurofins Scientific acquired TestAmerica, a leading environmental testing laboratory group in the US. This helped Eurofins strengthen its presence in the US market.
  • In November 2018, Brooks Automation, Inc. acquired GENEWIZ group which will improve the company's global services of metagenomics sequencing.
  • In 2017, QIAGEN acquired OmicSoft Corporation (US), a management, visualization, and analysis software provider for bioinformatics, NGS, and cancer genomics.

Why Purchase the Report?

  • Visualize the composition of the metagenomic sequencing market segmentation by product & service, workflow, technology, and application highlighting the key commercial assets and players.
  • Identify commercial opportunities in metagenomic sequencing market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of metagenomic sequencing market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global metagenomic sequencing market report would provide an access to an approx. 69 market data table, 69 figures and 300 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Metagenomic Sequencing Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Metagenomic Sequencing Market - Market Definition and Overview

3. Global Metagenomic Sequencing Market - Executive Summary

  • 3.1. Market Snippet by Product & Service
  • 3.2. Market snippet by Technology
  • 3.3. Market snippet by Workflow
  • 3.4. Market Snippet by Application
  • 3.5. Market Snippet by Region

4. Global Metagenomic Sequencing Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing initiatives and funding for large-scale sequencing projects
      • 4.1.1.2. Large applications of metagenomics in various fields
      • 4.1.1.3. XX
    • 4.1.2. Restraints
      • 4.1.2.1. Budget constraints in developing countries
      • 4.1.2.2. Lack of skilled professionals
      • 4.1.2.3. XX
    • 4.1.3. Opportunity
      • 4.1.3.1. Emerging cloud computing for data management
    • 4.1.4. Impact Analysis

5. Global Metagenomic Sequencing Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Clinical Trials
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global Metagenomic Sequencing Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Metagenomic Sequencing Market - By Product & Service

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service Segment
  • 7.3. Market Attractiveness Index, By Product & Service Segment
    • 7.3.1. Instruments*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Reagents & Consumables
    • 7.3.3. Analyses & Data Interpretation Solutions
    • 7.3.4. Services
    • 7.3.5. Others

8. Global Metagenomic Sequencing Market - By Workflow

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
  • 8.3. Market Attractiveness Index, By Workflow Segment
    • 8.3.1. Data Processing & Analysis *
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Sample Processing & Library Preparation
    • 8.3.3. Sequencing

9. Global Metagenomic Sequencing Market - By Technology

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Segment
  • 9.3. Market Attractiveness Index, By Technology Segment
    • 9.3.1. Shotgun Metagenomic Sequencing*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. 16S rRNA Sequencing
    • 9.3.3. Whole Genome Sequencing & De Novo Assembly
    • 9.3.4. Metatranscriptomics

10. Global Metagenomic Sequencing Market - By Application

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 10.3. Market Attractiveness Index, By Application Segment
    • 10.3.1. Drug Discovery*
      • 10.3.1.1. Introduction
      • 10.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 10.3.2. Clinical Diagnostics
    • 10.3.3. Veterinary Applications
    • 10.3.4. Ecological and Environmental Applications
    • 10.3.5. Industrial applications
    • 10.3.6. Soil Microbiome Applications
    • 10.3.7. Others

11. Global Metagenomic Sequencing Market - By Region

  • 11.1. Introduction
  • 11.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 11.3. Market Attractiveness Index, By Region
  • 11.4. North America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. U.S.
      • 11.4.7.2. Canada
      • 11.4.7.3. Mexico
  • 11.5. Europe
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. Germany
      • 11.5.7.2. U.K.
      • 11.5.7.3. France
      • 11.5.7.4. Italy
      • 11.5.7.5. Spain
      • 11.5.7.6. Rest of Europe
  • 11.6. South America
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.6.7.1. Brazil
      • 11.6.7.2. Argentina
      • 11.6.7.3. Rest of South America
  • 11.7. Asia Pacific
    • 11.7.1. Introduction
    • 11.7.2. Key Region-Specific Dynamics
    • 11.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
    • 11.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
    • 11.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.7.7.1. China
      • 11.7.7.2. India
      • 11.7.7.3. Japan
      • 11.7.7.4. Australia
      • 11.7.7.5. Rest of Asia Pacific
  • 11.8. Middle East and Africa
    • 11.8.1. Introduction
    • 11.8.2. Key Region-Specific Dynamics
    • 11.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product & Service
    • 11.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Workflow
    • 11.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

12. Global Metagenomic Sequencing Market - Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Global Metagenomic Sequencing Market- Company Profiles

  • 13.1. Thermo Fisher Scientific Inc.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Qiagen N.V.
  • 13.3. BGI Group
  • 13.4. DNAstar, Inc.
  • 13.5. Eurofins Scientific
  • 13.6. Illumina, Inc.
  • 13.7. Macrogen, Inc.
  • 13.8. Oxford Nanopore Technologies Ltd.
  • 13.9. NuGEN Technologies, Inc. (A Wholly Owned Subsidiary of Tecan Trading AG)
  • 13.10. F. Hoffmann-La Roche Ltd.
  • 13.11. Perkinelmer, Inc.
  • 13.12. Integragen SA
  • 13.13. Microsynth AG
  • 13.14. Novogene Co., Ltd.
  • 13.15. Zymo Research Corporation

LIST NOT EXHAUSTIVE

14. Global Metagenomic Sequencing Market - Premium Insights

15. Global Metagenomic Sequencing Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us